{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:46Z","timestamp":1786980526744,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10067-023-06569-w","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T11:03:37Z","timestamp":1678359817000},"page":"1665-1674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"42","author":[{"given":"Maynart","family":"Sukharomana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-6039","authenticated-orcid":false,"given":"Sirirat","family":"Charuvanij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"6569_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"6569_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/msc.1393","volume":"17","author":"S Charuvanij","year":"2019","unstructured":"Charuvanij S, Chaiyadech C (2019) Health-related quality of life in children with early-stage juvenile idiopathic arthritis. Musculoskeletal Care 17:215\u2013220. https:\/\/doi.org\/10.1002\/msc.1393","journal-title":"Musculoskeletal Care"},{"issue":"Suppl. 1","key":"6569_CR3","doi-asserted-by":"publisher","first-page":"P176","DOI":"10.1186\/s12969-021-00632-z","volume":"19","author":"S Tangcheewinsirikul","year":"2021","unstructured":"Tangcheewinsirikul S, Sukharomana M, Charuvanij S (2021) Damage and disability in children with juvenile idiopathic arthritis: a study from Thailand. Pediatr Rheumatol Online J 19(Suppl. 1):P176. https:\/\/doi.org\/10.1186\/s12969-021-00632-z","journal-title":"Pediatr Rheumatol Online J"},{"key":"6569_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM et al (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63:465\u2013482. https:\/\/doi.org\/10.1002\/acr.20460","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6569_CR5","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.38092","volume":"65","author":"S Ringold","year":"2013","unstructured":"Ringold S, Weiss PF, Beukelman T, DeWitt EM, Ilowite NT, Kimura Y et al (2013) 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum 65:2499\u20132512. https:\/\/doi.org\/10.1002\/art.38092","journal-title":"Arthritis Rheum"},{"key":"6569_CR6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/art.40884","volume":"71","author":"S Ringold","year":"2019","unstructured":"Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML et al (2019) 2019 American College of Rheumatology\/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis. Arthritis Rheumatol 71:846\u2013863. https:\/\/doi.org\/10.1002\/art.40884","journal-title":"Arthritis Rheumatol"},{"key":"6569_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00296-010-1365-x","volume":"31","author":"BJ Bloom","year":"2011","unstructured":"Bloom BJ, Alario AJ, Miller LC (2011) Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review. Rheumatol Int 31:749\u2013756. https:\/\/doi.org\/10.1007\/s00296-010-1365-x","journal-title":"Rheumatol Int"},{"key":"6569_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00431-007-0525-9","volume":"167","author":"P Marti","year":"2008","unstructured":"Marti P, Molinari L, Bolt IB, Seger R, Saurenmann RK (2008) Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis. Eur J Pediatr 167:425\u2013430. https:\/\/doi.org\/10.1007\/s00431-007-0525-9","journal-title":"Eur J Pediatr"},{"key":"6569_CR9","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/1529-0131(199911)42:11","volume":"42","author":"DD Sherry","year":"1999","unstructured":"Sherry DD, Stein LD, Reed AM, Schanberg LE, Kredich DW (1999) Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum 42:2330\u20132334. https:\/\/doi.org\/10.1002\/1529-0131(199911)42:11","journal-title":"Arthritis Rheum"},{"key":"6569_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/adc.88.3.192","volume":"88","author":"AG Cleary","year":"2003","unstructured":"Cleary AG, Murphy HD, Davidson JE (2003) Intra-articular corticosteroid injections in juvenile idiopathic arthritis. Arch Dis Child 88:192\u2013196","journal-title":"Arch Dis Child"},{"key":"6569_CR11","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s10067-014-2572-8","volume":"33","author":"N Garg","year":"2014","unstructured":"Garg N, Perry L, Deodhar A (2014) Intra-articular and soft tissue injections, a systematic review of relative efficacy of various corticosteroids. Clin Rheumatol 33:1695\u20131706. https:\/\/doi.org\/10.1007\/s10067-014-2572-8","journal-title":"Clin Rheumatol"},{"key":"6569_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/art.1790070309","volume":"7","author":"LM Centeno","year":"1994","unstructured":"Centeno LM, Moore ME (1994) Preferred intraarticular corticosteroids and associated practice: a survey of members of the American College of Rheumatology. Arthritis Care Res 7:151\u2013155","journal-title":"Arthritis Care Res"},{"key":"6569_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12969-020-00475-0","volume":"18","author":"A Dhanrajani","year":"2020","unstructured":"Dhanrajani A, Khubchandani RP (2020) Joint injection practice variations in pediatric rheumatology - a global survey and call for action. Pediatr Rheumatol Online J 18:81. https:\/\/doi.org\/10.1186\/s12969-020-00475-0","journal-title":"Pediatr Rheumatol Online J"},{"key":"6569_CR14","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/rheumatology\/keg358","volume":"42","author":"F Zulian","year":"2003","unstructured":"Zulian F, Martini G, Gobber D, Agosto C, Gigante C, Zacchello F (2003) Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 42:1254\u20131259. https:\/\/doi.org\/10.1093\/rheumatology\/keg358","journal-title":"Rheumatology (Oxford)"},{"key":"6569_CR15","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/rheumatology\/keh313","volume":"43","author":"F Zulian","year":"2004","unstructured":"Zulian F, Martini G, Gobber D, Plebani M, Zacchello F, Manners P (2004) Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology (Oxford) 43:1288\u20131291. https:\/\/doi.org\/10.1093\/rheumatology\/keh313","journal-title":"Rheumatology (Oxford)"},{"key":"6569_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.rbre.2016.01.001","volume":"56","author":"AL Cunha","year":"2016","unstructured":"Cunha AL, Miotto ESVB, Osaku FM, Niemxeski LB, Furtado RN, Natour J et al (2016) Intra-articular injection in patients with juvenile idiopathic arthritis: factors associated with a good response. Rev Bras Reumatol Engl Ed 56:490\u2013496. https:\/\/doi.org\/10.1016\/j.rbre.2016.01.001","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"6569_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(17)30065-X","volume":"389","author":"A Ravelli","year":"2017","unstructured":"Ravelli A, Davi S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EHP et al (2017) Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. Lancet 389:909\u2013916. https:\/\/doi.org\/10.1016\/S0140-6736(17)30065-X","journal-title":"Lancet"},{"key":"6569_CR18","first-page":"2100","volume":"28","author":"A Ravelli","year":"2001","unstructured":"Ravelli A, Manzoni SM, Viola S, Pistorio A, Ruperto N, Martini A (2001) Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis. J Rheumatol 28:2100\u20132102","journal-title":"J Rheumatol"},{"key":"6569_CR19","first-page":"2696","volume":"27","author":"W Breit","year":"2000","unstructured":"Breit W, Frosch M, Meyer U, Heinecke A, Ganser G (2000) A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J Rheumatol 27:2696\u20132702","journal-title":"J Rheumatol"},{"key":"6569_CR20","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/rheumatology\/ker165","volume":"50","author":"S Lanni","year":"2011","unstructured":"Lanni S, Bertamino M, Consolaro A, Pistorio A, Magni-Manzoni S, Galasso R et al (2011) Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis. Rheumatology (Oxford) 50:1627\u20131634. https:\/\/doi.org\/10.1093\/rheumatology\/ker165","journal-title":"Rheumatology (Oxford)"},{"key":"6569_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41927-022-00249-z","volume":"6","author":"A Chun","year":"2022","unstructured":"Chun A, Muhammad LN, De Ranieri D (2022) Comparison of efficacy between triamcinolone acetonide and triamcinolone hexacetonide for intraarticular therapy in juvenile idiopathic arthritis: a retrospective analysis. BMC Rheumatol 6:18. https:\/\/doi.org\/10.1186\/s41927-022-00249-z","journal-title":"BMC Rheumatol"},{"key":"6569_CR22","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1651-2227.1993.tb12815.x","volume":"82","author":"VE Honkanen","year":"1993","unstructured":"Honkanen VE, Rautonen JK, Pelkonen PM (1993) Intra-articular glucocorticoids in early juvenile chronic arthritis. Acta Paediatr 82:1072\u20131074. https:\/\/doi.org\/10.1111\/j.1651-2227.1993.tb12815.x","journal-title":"Acta Paediatr"},{"key":"6569_CR23","first-page":"719","volume":"20","author":"L Lepore","year":"2002","unstructured":"Lepore L, Del Santo M, Malorgio C, Presani G, Perticarari S, Prodan M et al (2002) Treatment of juvenile idiopathic arthritis with intra-articular triamcinolone hexacetonide: evaluation of clinical effectiveness correlated with circulating ANA and T gamma\/delta + and B CD5+ lymphocyte populations of synovial fluid. Clin Exp Rheumatol 20:719\u2013722","journal-title":"Clin Exp Rheumatol"},{"key":"6569_CR24","doi-asserted-by":"publisher","first-page":"822009","DOI":"10.3389\/fped.2022.822009","volume":"10","author":"S Li","year":"2022","unstructured":"Li S, Zhang W, Lin Y (2022) Application of intra-articular corticosteroid injection in juvenile idiopathic arthritis. Front Pediatr 10:822009. https:\/\/doi.org\/10.3389\/fped.2022.822009","journal-title":"Front Pediatr"},{"key":"6569_CR25","first-page":"995","volume":"45","author":"E Unsal","year":"2008","unstructured":"Unsal E, Makay B (2008) Intraarticular triamcinolone in juvenile idiopathic arthritis. Indian Pediatr 45:995\u2013997","journal-title":"Indian Pediatr"},{"key":"6569_CR26","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4:e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"key":"6569_CR27","unstructured":"The EQUATOR Network [Accessed 3 Jan 2023]. Available from: https:\/\/www.equator-network.org\/"},{"key":"6569_CR28","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s10067-022-06238-4","volume":"41","author":"A Barajas-Ochoa","year":"2022","unstructured":"Barajas-Ochoa A, Cisneros-Barrios A, Ramos-Remus C (2022) Evaluation of the quality and subsequent performance of manuscripts rejected by Clinical Rheumatology: a research report. Clin Rheumatol 41:2541\u20132551. https:\/\/doi.org\/10.1007\/s10067-022-06238-4","journal-title":"Clin Rheumatol"},{"key":"6569_CR29","first-page":"2507","volume":"31","author":"BA Eberhard","year":"2004","unstructured":"Eberhard BA, Sison MC, Gottlieb BS, Ilowite NT (2004) Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 31:2507\u20132512","journal-title":"J Rheumatol"},{"key":"6569_CR30","doi-asserted-by":"publisher","unstructured":"Hertzberger-ten Cate R, de Vries-van der Vlugt BC, van Suijlekom-Smit LW, Cats A (1991) Intra-articular steroids in pauciarticular juvenile chronic arthritis, type 1. Eur J Pediatr 150:170\u2013172. https:\/\/doi.org\/10.1007\/BF01963559","DOI":"10.1007\/BF01963559"},{"key":"6569_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/art.1780290808","volume":"29","author":"RC Allen","year":"1986","unstructured":"Allen RC, Gross KR, Laxer RM, Malleson PN, Beauchamp RD, Petty RE (1986) Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children. Arthritis Rheum 29:997\u20131001","journal-title":"Arthritis Rheum"},{"key":"6569_CR32","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/1529-0131(199807)41:7<1210::AID-ART10>3.0.CO;2-5","volume":"41","author":"S Padeh","year":"1998","unstructured":"Padeh S, Passwell JH (1998) Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 41:1210\u20131214. https:\/\/doi.org\/10.1002\/1529-0131(199807)41:7%3c1210::AID-ART10%3e3.0.CO;2-5","journal-title":"Arthritis Rheum"},{"key":"6569_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0022-3476(95)70320-9","volume":"127","author":"HI Huppertz","year":"1995","unstructured":"Huppertz HI, Tschammler A, Horwitz AE, Schwab KO (1995) Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J Pediatr 127:317\u2013321","journal-title":"J Pediatr"},{"key":"6569_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12969-021-00520-6","volume":"19","author":"R Harhay","year":"2021","unstructured":"Harhay R, Jeelani W, Agbor BTA, Hennon T, Wrotniak BH, Abdul-Aziz R (2021) Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis. Pediatr Rheumatol Online J 19:36. https:\/\/doi.org\/10.1186\/s12969-021-00520-6","journal-title":"Pediatr Rheumatol Online J"},{"key":"6569_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12969-021-00498-1","volume":"19","author":"S Tangcheewinsirikul","year":"2021","unstructured":"Tangcheewinsirikul S, Tang SP, Smith N, Sukharomana M, Charuvanij S, Vilaiyuk S et al (2021) Delivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regions. Pediatr Rheumatol Online J 19:11. https:\/\/doi.org\/10.1186\/s12969-021-00498-1","journal-title":"Pediatr Rheumatol Online J"},{"key":"6569_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41584-020-0368-6","volume":"16","author":"HE Foster","year":"2020","unstructured":"Foster HE, Scott C (2020) Update the WHO EML to improve global paediatric rheumatology. Nat Rev Rheumatol 16:123. https:\/\/doi.org\/10.1038\/s41584-020-0368-6","journal-title":"Nat Rev Rheumatol"},{"key":"6569_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12969-021-00496-3","volume":"19","author":"C Scott","year":"2021","unstructured":"Scott C, Smith N, James R, Whitehead B, Green R, Foster HE et al (2021) Revising the WHO Essential Medicines List for paediatric rheumatology. Pediatr Rheumatol Online J 19:10. https:\/\/doi.org\/10.1186\/s12969-021-00496-3","journal-title":"Pediatr Rheumatol Online J"},{"key":"6569_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12969-022-00752-0","volume":"20","author":"W Slamang","year":"2022","unstructured":"Slamang W, Smith N, Scott C, Foster H, Paediatric Global MSKTF (2022) Revising the WHO Essential Medicines List for paediatric rheumatology update. Pediatr Rheumatol Online J 20:89. https:\/\/doi.org\/10.1186\/s12969-022-00752-0","journal-title":"Pediatr Rheumatol Online J"},{"key":"6569_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12969-022-00770-y","volume":"20","author":"T Hahn","year":"2022","unstructured":"Hahn T, Daymont C, Beukelman T, Groh B, Hays K, Bingham CA et al (2022) Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatr Rheumatol Online J 20:107. https:\/\/doi.org\/10.1186\/s12969-022-00770-y","journal-title":"Pediatr Rheumatol Online J"},{"key":"6569_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semarthrit.2012.12.006","volume":"43","author":"O Goldzweig","year":"2013","unstructured":"Goldzweig O, Carrasco R, Hashkes PJ (2013) Systemic adverse events following intraarticular corticosteroid injections for the treatment of juvenile idiopathic arthritis: two patients with dermatologic adverse events and review of the literature. Semin Arthritis Rheum 43:71\u201376. https:\/\/doi.org\/10.1016\/j.semarthrit.2012.12.006","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06569-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T03:07:16Z","timestamp":1684724836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06569-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6569"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06569-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"18 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}